Conjunctival necrosis after administration of topical fortified aminoglycosides.

[1]  J. Nauheim,et al.  Bulbar conjunctival defects associated with gentamicin. , 1987, Archives of ophthalmology.

[2]  M. L. Gilbert,et al.  Tobramycin in ophthalmology. , 1987, Survey of ophthalmology.

[3]  M. L. Gilbert,et al.  Comparative bioavailability and efficacy of fortified topical tobramycin. , 1987, Investigative ophthalmology & visual science.

[4]  M. Hashiguchi,et al.  Biochemical mechanisms of aminoglycoside cell toxicity. I. The uptake of gentamicin by cultured skin fibroblasts and the alteration of lysosomal enzyme activities. , 1986, Journal of biochemistry.

[5]  Y. Pouliquen,et al.  Antibiotics and corneal epithelial wound healing. , 1983, Archives of ophthalmology.

[6]  G. Stern,et al.  Effect of topical antibiotic solutions on corneal epithelial wound healing. , 1983, Archives of ophthalmology.

[7]  J. Baum,et al.  Topical vs subconjunctival treatment of bacterial corneal ulcers. , 1983, Ophthalmology.

[8]  P. Laibson,et al.  A clinical comparison of tobramycin and gentamicin sulfate in the treatment of ocular infections. , 1981, American journal of ophthalmology.

[9]  F. M. Wilson.  Adverse external ocular effects of topical ophthalmic medications. , 1979, Survey of ophthalmology.

[10]  J. Baum.  Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms. , 1979, Survey of ophthalmology.

[11]  H. Leibowitz,et al.  Topical antibiotic therapy of Pseudomonas aeruginosa keratitis. , 1979, Archives of ophthalmology.

[12]  D. Jones,et al.  Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears. , 1979, Survey of ophthalmology.

[13]  P. Tulkens,et al.  Cellular toxicity of gentamicin. , 1979, American journal of ophthalmology.

[14]  J. Baum,et al.  Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. , 1977, American journal of ophthalmology.

[15]  R. Weeks,et al.  Corneal distribution of subconjunctival antibiotics. , 1976, American journal of ophthalmology.

[16]  A. Gasset,et al.  Cytotoxicity of ophthalmic preservatives. , 1974, American journal of ophthalmology.

[17]  G. Smolin,et al.  The effect of tobramycin on gentamicin-resistant strains in Pseudomonas keratitis. , 1974, American journal of ophthalmology.

[18]  J. Baum.  Therapy for ocular bacterial infection. , 1986, Transactions of the ophthalmological societies of the United Kingdom.

[19]  W. nd.  Adverse external ocular effects of topical ophthalmic therapy: an epidemiologic, laboratory, and clinical study. , 1983 .

[20]  D. S. Davis,et al.  Tobramycin in external eye disease: a double-masked study vs. gentamicin. , 1981, Current eye research.

[21]  S. Davis,et al.  Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study. , 1981, Current eye research.

[22]  R. Hyndiuk,et al.  Topical tobramycin therapy of experimental Pseudomonas keratitis: an evaluation of some factors that potentially enhance efficacy. , 1978, Archives of ophthalmology.